Clinical
Next gen progestogen-only pill (POP) added to PBS
Oral contraceptive with 24-hour missed pill window added to PBS, along with combination therapy for women with fertility issues Around 80,000 Australian women paying privately for the progestogen-only oral contraceptive …
Changing direction
TGA delegate overturns interim decisions on schedule changes to products containing widely used ingredients The Therapeutic Goods Administration’s (TGA) medicines scheduling committee has overturned previous interim decisions on scheduling products …
‘Use AI, but don’t rely on it for everything’
A leading pharmacist says it’s “inevitable” that AI will soon change the face of pharmacy practice, but argues that the “human touch has to remain” Associate Professor Betty Chaar is …
Playing a leading role
With pharmacist vaccinations continuing to expand, we review the space, and see how others have safely rolled out vax programs in their pharmacies It’s safe to say the pharmacist workforce …
February MIMS update
Some of the recent changes to the medicines landscape, with new products, indications and contraindications New Products RelabotulinumtoxinA (Relfydess) is a Clostridium botulinum type A neurotoxin product that blocks the …
January MIMS Update
Some of the recent changes to the medicines landscape, with new products, indications and safety-related changes New Products Amivantamab (Rybrevant) is a low-fucose, fully-human IgG1-based bispecific antibody that binds to …
Paracetamol recommendations not yet addressed: CHP
While it supports the incoming paracetamol scheduling changes, industry group says some advisory recommendations remain to be addressed As the 1 February deadline swiftly approaches for the implementation revised scheduling …
No change for sildenafil
Scheduling for ED treatment to remain prescription only despite pharmacist support for change Leading erectile dysfunction treatment sildenafil will remain as a Schedule 4 (prescription only) treatment after a down …
Medication info at discharge impacts ED, readmission risk
Patients who receive contradictory information are at higher risk of readmission and subsequent ED visit, but thorough medication counselling lowers risk, study finds Hospital patients prescribed a new medication at …
Pharmacists ‘crucial’ in supporting safe supplement use: BioCeuticals
Adverse reactions linked to popular “practitioner only” supplements highlight role of pharmacists Patients with pre-existing conditions are being urged to consult a health professional before taking any new product, following …
December MIMS Update
Some of the recent changes to the medicines landscape, with new products and indications New Products Bretovameran (Comirnaty JN.1) is a nucleoside-modified messenger RNA formulated in lipid nanoparticles, which enable …
The top 12: Clinical news
We continue our look at the major stories of the year by looking at the most widely read clinical news, including schedule changes, vapes, warnings and a methadone-related death These …